Get started
Author

Matteo Piccica

Observed name: M Piccica
ORCID: 0000-0002-2054-9725
Observed ORCID: 0000-0002-2054-9725
OpenAlex ID: A5082865023
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020
2020 · Filippo Lagi, Matteo Piccica, et al. · Eurosurveillance · 61
Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review
2021 · Matteo Piccica, Filippo Lagi, et al. · Journal of Travel Medicine · 55
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience
2023 · Matteo Piccica, Michele Spinicci, et al. · Journal of Antimicrobial Chemotherapy · 37
PDF
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy
2021 · Filippo Lagi, Sasha Trevisan, et al. · International Journal of Infectious Diseases · 19
PDF
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study
2024 · Anna Barbiero, Michele Spinicci, et al. · Microorganisms · 17
PDF
Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate
2020 · Gregorio Basile, Glauco Cristofaro, et al. · International Journal of Infectious Diseases · 14
PDF
High-dose steroids for the treatment of severe COVID-19
2021 · For the COCORA Working Group, Matteo Piccica, et al. · Internal and Emergency Medicine · 11
PDF
The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction
2021 · Luca Giovanni Locatello, Chiara Bruno, et al. · Cytokine · 10
PDF
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19
2020 · Chiara Bruno, Luca Giovanni Locatello, et al. · Allergy & Rhinology · 9
Cancer population may be paradoxically protected from severe manifestations of COVID-19
2020 · Oreste Gallo, Luca Giovanni Locatello, et al. · Journal of Infection · 6
PDF
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they?
2024 · Claudia Bartalucci, Federico Baldi, et al. · AIDS · 3
Disseminated Talaromyces infection in an AIDS patient
2021 · Gregorio Basile, Matteo Piccica, et al. · Clinical Microbiology and Infection · 3
PDF
Disseminated and Relapsing Cryptococcosis: What We Still Have to Learn—a Case Series and Review of Literature
2021 · Annarita Botta, Matteo Piccica, et al. · SN Comprehensive Clinical Medicine · 2
PDF
Tolvaptan efficacy and drug-drug interactions
2020 · Matteo Piccica, Gregorio Basile, et al. · Minerva Endocrinology · 2
A rare case of prothrombin time prolongation
2020 · Eleonora Camilleri, Niccolò Maggini, et al. · Internal and Emergency Medicine · 2
Durability of Long‐Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)
2025 · Filippo Lagi, Giuseppe Formica, et al. · Journal of Medical Virology · 1
Antibiotic-loaded calcium sulphate beads in in debridement, antibiotics, and implant retention (DAIR) for acute hip and knee periprosthetic joint infection: a retrospective comparative cohort study
2026 · Antonio Pirozzi, Francesco Raspanti, et al. · European Journal of Orthopaedic Surgery & Traumatology
Modular intramedullary knee arthrodesis for chronic periprosthetic joint infection after total knee arthroplasty: Patient-reported satisfaction and functional outcomes
2026 · Jacopo Corti, Francesco Raspanti, et al. · The Knee
P27 Durability and reasons for discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed adults with HIV: a multicenter real-world experience in Tuscany (LAHIV)
2026 · F Lagi, S Trevisan, et al. · Sexually Transmitted Infections
A Rare Case of Prosthetic Joint Infection Caused by Group D Salmonella
2026 · Anna Barbiero, Lucia Graziani, et al. · Case Reports in Infectious Diseases
PDF
P95 Metabolic and immunological outcomes after switching to long-acting cabotegravir + rilpivirine: a 44-week multicenter observational study (LAHIV)
2025 · F Lagi, M Fognani, et al. · Sexually Transmitted Infections
SC30 Real-world discontinuation and virological outcomes of long-acting cabotegravir + rilpivirine in virologically suppressed adults living with HIV: a multicenter observational study in Tuscany (LAHIV)
2025 · F Lagi, G Formica, et al. · Sexually Transmitted Infections
P-59 Neutral metabolic impact of long-acting CAB+RPV in PLWH: a Tuscan multicenter observational study (LAHIV)
2024 · F Lagi, G Formica, et al. · Sexually Transmitted Infections
PDF
P-60 Efficacy, safety and discontinuation of rilpivirine and cabotegravir in HIV-1 virologically suppressed adults: a multicenter observational study in Tuscany (LAHIV study)
2024 · F Lagi, G Formica, et al. · Sexually Transmitted Infections
PDF
Hookworm infection presenting as recurrent severe anaemia requiring blood transfusion in a Pakistani migrant to Italy
2021 · Giorgia Barbarisi, Matteo Piccica, et al. · Journal of Travel Medicine
Works count: 26
Citation count: 252
H-index: 9
I10-index: 8
Year
Topic
Type